INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 41 filers reported holding INTEC PHARMA LTD JERUSALEM in Q1 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,805,000 | -35.5% | 415,989 | +9.0% | 0.68% | -43.7% |
| Q1 2019 | $2,799,000 | -19.9% | 381,789 | -17.6% | 1.21% | -30.5% |
| Q4 2018 | $3,493,000 | +15.1% | 463,228 | -13.7% | 1.74% | +39.4% |
| Q3 2018 | $3,034,000 | +21.3% | 537,000 | -5.6% | 1.25% | +6.4% |
| Q2 2018 | $2,502,000 | +355.7% | 568,600 | +376.6% | 1.17% | +169.2% |
| Q2 2016 | $549,000 | +11.8% | 119,296 | 0.0% | 0.44% | +2.6% |
| Q1 2016 | $491,000 | -23.2% | 119,296 | 0.0% | 0.42% | -25.6% |
| Q4 2015 | $639,000 | -15.5% | 119,296 | -11.6% | 0.57% | -24.0% |
| Q3 2015 | $756,000 | – | 135,000 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 630,000 | $3,528,000 | 1.74% |
| DAFNA Capital Management LLC | 135,000 | $756,000 | 0.75% |
| Cormorant Asset Management, LP | 800,000 | $4,480,000 | 0.72% |
| Perceptive Advisors | 700,000 | $3,920,000 | 0.16% |
| SABBY MANAGEMENT, LLC | 613,910 | $3,438,000 | 0.14% |
| Ion Asset Management Ltd. | 10,000 | $56,000 | 0.08% |
| JANE STREET GROUP, LLC | 34,317 | $194,000 | 0.00% |
| UBS Group AG | 1,296 | $7,000 | 0.00% |